High mobility group box 3 pseudogene 6 (HMGB3P6)

High mobility group box 3 pseudogene 6 (HMGB3P6) is a processed, non-protein-coding pseudogene with high sequence homology to the HMGB3 gene[1][6]. Pseudogenes like HMGB3P6 are generally incapable of producing functional proteins and are considered non-essential. While some pseudogenes can generate regulatory RNAs affecting the expression of their parent genes or participate in RNA interference pathways, there is no evidence that HMGB3P6 has such roles[2][4]. HMGB3P6 is not classified as a therapeutic target, receptor, enzyme, or transporter[1][6]. No disease roles, biomarkers, or drug interactions have been established for this gene[1][2]. HMGB3P6 is annotated as a pseudogene in genetic databases, with its naming following standard conventions for human pseudogenes, where “P” and an ordinal number reflect the relationship to the parent gene family (here, HMGB3)[1][6]. Pseudogenes are defined as non-coding sequences that arise from functional genes but have lost the ability to encode a protein due to disruptive mutations or truncations[6]. Some pseudogenes can influence gene regulation under specific circumstances, especially via RNA-mediated mechanisms, but HMGB3P6 has not been characterized as having such a function[2][4]. No functional protein product for HMGB3P6 is known, nor are there any described roles in therapy, pathogenesis, or as a biomarker[1]. If further evidence is required for unlisted synonyms, rare regulatory potential, or updated functional details, this may require additional primary literature review. However, by established sources, HMGB3P6 remains a non-coding pseudogene without recognized therapeutic or functional significance.

Other names

High-mobility group box 2 pseudogeneHMGB3P6HMGB2 pseudogenehigh mobility group box 3 pseudogene 6